ArticleEcancermedicalscience2021
Mapping of colorectal cancer scientific landscape between South Africa and Brazil: a bibliometric analysis.
Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe five BRICS (Brazil, Russian, Indian, China and South Africa) countries bear a significant proportion of the world's global cancer burden.
aimThe aim of this paper is to map the scientific landscape related to colorectal cancer (CRC) research published related to South Africa (SA) and Brazil (BRA).
methodsWe used the bibliometric analysis technique to identify and map the scientific publications on CRC related to SA and BRA. We identified the document type, authors, research organisations, countries, funding sources, most relevant journals, research areas, citation reference counts, journal impact factor (IF) and open access designations in CRC scientific landscape for both countries. We analysed publications from January 2000 to August 2020 as indexed in the Web of Science Core Collection, most covering scientific medical related research and used descriptive statistical data analysis to synthesise the data.
findingsDuring the period 2000-2020, there were 80 and 176 peer-reviewed publications on CRC related to SA and BRA, respectively. The majority were original research articles. Sixty-six percent identified had a primary (first) author affiliated to SA research institution and 87% had primary author affiliated to the BRA research institution. Overall, 275 authors published CRC related to SA and 1,025 authors published CRC related to BRA. The leading research organisation in SA was the University of Witwatersrand (Wits, 26%) and was the University of Sao Paulo (23%) for in BRA. The publications, related to both countries, mostly focused on oncology. The South African Medical Journal (10%) produced the most articles for SA with IF = 1.285; and the Value in Health (7%) for BRA with IF = 1.736. The median cited reference count was 32 for SA publications and 34 for BRA publications. There were 49% and 39% of publications without any open access designations for SA and BRA, respectively.
conclusionsMapping CRC scientific publications highlighted potential benefits of developing an informed CRC national research plan in each country to promote concerted effort to better understand the risk factors, treatment and advocate for funding as stimulus for increased CRC research outputs that can inform policy development and influence practice to help reduce and control the CRC burden in both countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.